# 119-hr-3162: Affordable and Safe Prescription Drug Importation Act of 2025

119-hr-3162, Affordable and Safe Prescription Drug Importation Act of 2025, is a 119th Congress bill sponsored by Rep. Schakowsky, Janice D. [D-IL-9] (D-IL); status introduced; PRIA reads it as touching household money (as of 2026-10-11).

- Canonical: https://policyrisk.com/legislation/119-hr-3162
- As of: 2026-10-11
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Bill: 119-hr-3162
- Congress: 119
- Title: Affordable and Safe Prescription Drug Importation Act of 2025
- Status: introduced
- Introduced: 2025-05-01
- Sponsor: Rep. Schakowsky, Janice D. [D-IL-9] (D-IL)
- Cosponsors: 9
- Policy area: Health
- Touches household money: yes
- Last recorded action: 2026-10-11

## Summary

**Creates a federal framework to allow importation of certain prescription drugs.** The bill aims to lower U.S. drug costs while protecting safety, quality, and supply-chain integrity through certification, testing, and oversight. - Patients and families could access qualifying lower-cost drugs imported from Canada, the United Kingdom, the European Union, and Switzerland, with additional countries allowed after one year. Individuals may also import for personal use under program rules and case-by-case guidance. - Pharmacies and wholesale distributors can participate but must buy from registered facilities and certified foreign sellers, meet import-tracing duties, and provide biannual reports. Foreign sellers face certification and recertification every two years and may be suspended for noncompliance. - Safety and enforcement tighten supply controls with required English labeling, testing, adverse-event reporting, and recall procedures. The Secretary of Health and Human Services runs a phased rollout and oversight, the bill adds criminal penalties for internet-enabled illegal drug sales (up to 10 years imprisonment or a fine up to $250,000), and HHS and the Government Accountability Office must report on outcomes.

## Cosponsors (9)

- Rep. Neguse, Joe [D-CO-2] (D-CO), 2026-10-09T00:00:00.000Z
- Rep. Cohen, Steve [D-TN-9] (D-TN), 2025-05-01T00:00:00.000Z
- Rep. Doggett, Lloyd [D-TX-37] (D-TX), 2025-05-01T00:00:00.000Z
- Rep. Omar, Ilhan [D-MN-5] (D-MN), 2025-05-01T00:00:00.000Z
- Rep. Pingree, Chellie [D-ME-1] (D-ME), 2025-05-01T00:00:00.000Z
- Rep. Pocan, Mark [D-WI-2] (D-WI), 2025-05-01T00:00:00.000Z
- Rep. Ansari, Yassamin [D-AZ-3] (D-AZ), 2026-07-22T00:00:00.000Z
- Del. Norton, Eleanor Holmes [D-DC-At Large] (D-DC), 2026-08-03T00:00:00.000Z
- Rep. Casar, Greg [D-TX-35] (D-TX), 2026-08-03T00:00:00.000Z

## Provisions PRIA read

- New path to import lower-cost drugs: benefit, medium. The bill would direct HHS to set up national rules within 1 year to let pharmacies, wholesalers, and individuals import certain prescription drugs. At first, only certified sellers in Canada, the United Kingdom, EU countries, and Switzerland could sell to the U.S. Sellers would meet safety and test…
- Personal drug imports up to 90 days: benefit, medium. You would be able to buy up to a 90-day supply of a qualifying drug for personal use from a certified foreign pharmacy in Canada, the United Kingdom, EU countries, or Switzerland. The pharmacy would need a valid prescription from a U.S.-licensed practitioner, and the medicine could not be for resal…
- Ban drugmaker limits on import sellers: benefit, medium. The bill would bar drugmakers from charging certified foreign sellers higher prices or cutting off supply because they export to the U.S. It would also prohibit creating different versions just to block export or other actions to delay imports. There would be an exception for drugs on the official…
- Tougher penalties for unsafe online drug sales: benefit, low. Selling counterfeit or adulterated drugs online to people in the U.S., or shipping drugs online without a valid prescription, would become a crime. Violators could face up to 10 years in prison and fines up to $250,000.
- In-person doctor visit for import: cost, low. To use the import path, your prescriber would need to have seen you at least once in person. Telemedicine-only prescriptions would not meet this rule, which could mean extra time or travel for some patients.

## Related bills

- 119-hr-9877: Health Equity and Accountability Act of 2026
- 119-hr-7973: Momnibus Act
- 119-hr-7977: Energy Bills Relief Act
- 119-hr-3069: Medicare for All Act
- 119-hr-7853: PrEP Access and Coverage Act of 2026
- 119-hr-5361: George Floyd Justice in Policing Act of 2025

## Sources
- [119-hr-3162 on Congress.gov](https://www.congress.gov/bill/119th-congress/house-bill/3162)

## Related
- [119-hr-9877: Health Equity and Accountability Act of 2026](https://policyrisk.com/legislation/119-hr-9877)
- [119-hr-7973: Momnibus Act](https://policyrisk.com/legislation/119-hr-7973)
- [119-hr-7977: Energy Bills Relief Act](https://policyrisk.com/legislation/119-hr-7977)
- [119-hr-3069: Medicare for All Act](https://policyrisk.com/legislation/119-hr-3069)
- [119-hr-7853: PrEP Access and Coverage Act of 2026](https://policyrisk.com/legislation/119-hr-7853)
- [119-hr-5361: George Floyd Justice in Policing Act of 2025](https://policyrisk.com/legislation/119-hr-5361)
- [All bills in Congress](https://policyrisk.com/legislation)

Source: PRIA, https://policyrisk.com/legislation/119-hr-3162 (as of 2026-10-11).